Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00688311 · ClinicalTrials.gov registry record · NA
Pilot Trial of a Synbiotic in HIV+ Patients
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT00688311 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 34 participants.
The verdict
NCT00688311, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The goal of this study is to test the hypothesis that daily ingestion of a 'synbiotic' for 4 weeks will improve intestinal function, ease immune system overactivation, and increase blood CD4 count in HIV-infected individuals. A 'Synbiotic' is a mixture of probiotic bacteria and dietary fiber.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Synbiotic 2000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00688311
The ClinicalTrials.gov registry entry for NCT00688311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00688311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00688311 about?
NCT00688311 is a clinical study titled "Pilot Trial of a Synbiotic in HIV+ Patients". The goal of this study is to test the hypothesis that daily ingestion of a 'synbiotic' for 4 weeks will improve intestinal function, ease immune system overactivation, and increase blood CD4 count in HIV-infected individuals. A 'Synbiotic' is a mixture of probiotic bacteria and dietary fiber.
What is the current status of trial NCT00688311?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2008-05. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00688311?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Synbiotic 2000 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00688311?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.